SUBSCRIBE: Print / eNewsletter
NCI-Affiliated Oncologists Excluded From Narrow Insurance Networks
So-called “narrow network” healthcare plans are more likely to exclude oncologists who are associated with NCI-designated or NCCN Cancer Centers, according to a new study.
Fay Hlubocky on Recognizing and Addressing Clinician Burnout
In this interview we discuss the issue of burnout in oncology, including signs and risk factors, how it might affect patient care, and strategies for prevention.
Is There a Shortage of Oncologists?
With some analyses warning of an impending oncologist shortage, are we truly approaching a point of critical need? Are practice extenders such as advanced practitioners the best solution to fill that gap or are there other options?
FDA Announces Plan to Lower Nicotine in Cigarettes to Non-Addictive Levels
The FDA has announced a new comprehensive plan for tobacco and nicotine regulation designed to serve as a road map to better protect American children and reduce tobacco-related disease and death.
ACA Facilitates More Cancer Clinical Trial Participation
More privately insured cancer patients seeking to participate in clinical trials received approval since the passage of the Affordable Care Act, according to a new study.
Jeffrey Vacirca on How the COA Advocates for Community Oncology Practices and Patients
In this interview we discuss the goals of the Community Oncology Alliance, highlights from their annual meeting, and the challenge of transitioning cancer care to the hospital setting.
US Could Save Nearly $1 Billion With Pembrolizumab Dosing Change
This video examines how a change to weight-based pembrolizumab dosing in first-line PD-L1–positive lung cancer could save nearly $1 billion in US healthcare costs.
FDA Approves Immunotherapy for MSI-High or MMR-Deficient Tumors
The FDA has granted approval to pembrolizumab for pediatric and adult patients with microsatellite instability (MSI)-high or mismatch repair (MMR)-deficient solid tumors.
ACA Linked With Earlier Stage Cancer Diagnoses
The implementation of the Affordable Care Act, which increased insurance coverage, was associated with an increase in the diagnosis of several screenable cancers at an earlier stage.
How Do Oncology Professionals Feel About Possible ACA Repeal?
An NCCN survey taken during the period of congressional debate over new federal healthcare legislation, reports how oncology professionals feel about the possible repeal and replacement of the ACA.